These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20436437)

  • 21. Nitroglycerin sensitises in healthy subjects CNS structures involved in migraine pathophysiology: evidence from a study of nociceptive blink reflexes and visual evoked potentials.
    Di Clemente L; Coppola G; Magis D; Gérardy PY; Fumal A; De Pasqua V; Di Piero V; Schoenen J
    Pain; 2009 Jul; 144(1-2):156-61. PubMed ID: 19457613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
    Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
    Raskin J; Wiltse CG; Dinkel JJ; Walker DJ; Desaiah D; Katona C
    J Clin Psychopharmacol; 2008 Feb; 28(1):32-8. PubMed ID: 18204338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Crucitti A; Zhang Q; Nilsson M; Brecht S; Yang CR; Wernicke J
    Curr Med Res Opin; 2010 Nov; 26(11):2579-88. PubMed ID: 20874076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Migraine and temporomandibular joint dysfunction: mechanisms of comorbidity].
    Zenkevich AS; Filatova EG; Latysheva NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):33-38. PubMed ID: 26525619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive effects of AS1069562, the (+)-isomer of indeloxazine, on spinal hypersensitivity induced by intrathecal injection of prostaglandin in mice: comparison with duloxetine and amitriptyline.
    Murai N; Tsukamoto M; Tamura S; Aoki T; Matsuoka N
    Eur J Pharmacol; 2014 Jun; 733():54-61. PubMed ID: 24704374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.
    Liu X; Cui Z; Niu L; Faries DE; Ball T; Johnstone B
    Clin Ther; 2011 Nov; 33(11):1726-38. PubMed ID: 22019345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
    Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
    Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.
    Cui Z; Faries DE; Zhao Y; Novick D; Liu X
    J Med Econ; 2011; 14(5):662-72. PubMed ID: 21892857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine-related panic attacks.
    Sabljić V; Rakun R; Ružić K; Grahovac T
    Psychiatr Danub; 2011 Mar; 23(1):114-6. PubMed ID: 21448113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of persistent central sensitization in chronic headaches: a multi-method study.
    Filatova E; Latysheva N; Kurenkov A
    J Headache Pain; 2008 Oct; 9(5):295-300. PubMed ID: 18690491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine.
    Cui Z; Faries DE; Shen W; Able SL; Novick D
    J Med Econ; 2013; 16(5):623-32. PubMed ID: 23425292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nociceptive blink reflex and visual evoked potential habituations are correlated in migraine.
    Di Clemente L; Coppola G; Magis D; Fumal A; De Pasqua V; Schoenen J
    Headache; 2005; 45(10):1388-93. PubMed ID: 16324171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain.
    Nagashima W; Kimura H; Ito M; Tokura T; Arao M; Aleksic B; Yoshida K; Kurita K; Ozaki N
    Clin Neuropharmacol; 2012; 35(6):273-7. PubMed ID: 23123692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
    Pangallo BA; Zhang Q; Desaiah D; Perahia DG; Detke MJ; Kennedy SH
    Curr Med Res Opin; 2010 Nov; 26(11):2643-51. PubMed ID: 20932222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.